![David Stanley Bailey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Stanley Bailey
Gründer bei IOTA Pharmaceuticals Ltd.
Aktive Positionen von David Stanley Bailey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IOTA Pharmaceuticals Ltd.
![]() IOTA Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology IOTA Pharmaceuticals Ltd. is a pharmaceutical discovery services company. Its services include virtual screening packages, surface Plasmon resonance (SPR) screening package, high-sensitivity biochemical screening package, nuclear magnetic resonance (NMR) screening package, and co-crystallography of fragment-based leads. The company was founded by Paul England and David Bailey in 2007 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 05.09.2007 | - |
Gründer | 01.01.2007 | - |
Karriereverlauf von David Stanley Bailey
Ehemalige bekannte Positionen von David Stanley Bailey
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
De Novo Pharmaceuticals Ltd.
![]() De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Gründer | 28.04.1999 | - |
INCYTE CORPORATION | Corporate Officer/Principal | - | - |
University of London | Corporate Officer/Principal | - | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Purely Proteins Ltd.
![]() Purely Proteins Ltd. Pharmaceuticals: MajorHealth Technology Purely Proteins Ltd. provided supportive services for drug discovery. The firm also offered range of protein-based tools to aid drug discovery, research and development. The company was founded by David Bailey, Geeta Gupta, Christopher Robin Lowe and David J. Parry-Smith on July 16, 2002 and was headquartered in Madingley, the United Kingdom. | Gründer | 01.01.2002 | - |
Präsident | 01.01.2002 | - |
Ausbildung von David Stanley Bailey
University of Cambridge | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 6 |
Vereinigte Staaten | 3 |
Operativ
Founder | 3 |
Corporate Officer/Principal | 3 |
President | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
INCYTE CORPORATION | Health Technology |
PFIZER, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
De Novo Pharmaceuticals Ltd.
![]() De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
Purely Proteins Ltd.
![]() Purely Proteins Ltd. Pharmaceuticals: MajorHealth Technology Purely Proteins Ltd. provided supportive services for drug discovery. The firm also offered range of protein-based tools to aid drug discovery, research and development. The company was founded by David Bailey, Geeta Gupta, Christopher Robin Lowe and David J. Parry-Smith on July 16, 2002 and was headquartered in Madingley, the United Kingdom. | Health Technology |
IOTA Pharmaceuticals Ltd.
![]() IOTA Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology IOTA Pharmaceuticals Ltd. is a pharmaceutical discovery services company. Its services include virtual screening packages, surface Plasmon resonance (SPR) screening package, high-sensitivity biochemical screening package, nuclear magnetic resonance (NMR) screening package, and co-crystallography of fragment-based leads. The company was founded by Paul England and David Bailey in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- David Stanley Bailey
- Erfahrung